Inhibitors of activin receptor-like kinase
US-12595265-B2 · Apr 7, 2026 · US
This page is not indexed by search engines while we improve data quality.
Fleming Paul E patents
Fleming Paul E is listed as an inventor on 39 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Fleming Paul E |
| Total patents | 39 |
| First publication | May 5, 2015 |
| Latest publication | Apr 7, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Selective phd1 inhibitor compounds, compositions, and methods of use
US-2024336568-A1 · Oct 10, 2024 · US
Picolinamide compounds as selective phd1 inhibitors, compositions, and methods of use
US-2024327376-A1 · Oct 3, 2024 · US
Inhibitors of activin receptor-like kinase
US-2024158398-A1 · May 16, 2024 · US
Phd inhibitor compounds, compositions, and methods of use
US-2023295110-A1 · Sep 21, 2023 · US
Phd inhibitor compounds, compositions, and use
US-2023227426-A1 · Jul 20, 2023 · US
Phd inhibitor compounds, compositions, and their use
US-2023212138-A1 · Jul 6, 2023 · US
Phd inhibitor compounds, compositions, and use
US-2023159489-A1 · May 25, 2023 · US
Inhibitors of activin receptor-like kinase
US-11634422-B2 · Apr 25, 2023 · US
Inhibitors of activin receptor-like kinase
US-2022315585-A1 · Oct 6, 2022 · US
Recent patents
Latest publications not already listed above.
Substituted pyrrolopyridines as inhibitors of activin receptor-like kinase
US-11236086-B2 · Feb 1, 2022 · US
Substituted pyrrolopyridines as inhibitors of activin receptor-like kinase
US-2020331908-A1 · Oct 22, 2020 · US
2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors
US-10774070-B2 · Sep 15, 2020 · US
Heteroaryls and uses thereof
US-10538533-B2 · Jan 21, 2020 · US
2-(pyridin-3-yl)-pyrimidine derivatives as ret inhibitors
US-2019359591-A1 · Nov 28, 2019 · US
Inhibitors of activin receptor-like kinase
US-10233186-B2 · Mar 19, 2019 · US
Compounds useful for treating disorders related to RET
US-10227329-B2 · Mar 12, 2019 · US
2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors
US-10202365-B2 · Feb 12, 2019 · US
Heteroaryls and uses thereof
US-10202373-B2 · Feb 12, 2019 · US
Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme
US-10202389-B2 · Feb 12, 2019 · US
Derivatives of 1-amino-2-cyclobutylethylboronic acid
US-10035811-B2 · Jul 31, 2018 · US
Heteroaryls and uses thereof
US-2018118762-A1 · May 3, 2018 · US
2-(pyridin-3-yl)-pyrimidine derivatives as ret inhibitors
US-2018022731-A1 · Jan 25, 2018 · US
Compounds useful for treating disorders related to ret
US-2018022732-A1 · Jan 25, 2018 · US
Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme
US-2017369499-A1 · Dec 28, 2017 · US
Derivatives of 1-amino-2-cyclobutylethylboronic acid
US-2017349611-A1 · Dec 7, 2017 · US
Heteroaryls and uses thereof
US-9802960-B2 · Oct 31, 2017 · US
Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme
US-9796725-B2 · Oct 24, 2017 · US
Inhibitors of activin receptor-like kinase
US-2017298069-A1 · Oct 19, 2017 · US
Derivatives of 1-amino-2-cyclobutylethylboronic acid
US-9771381-B2 · Sep 26, 2017 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Millennium Pharm Inc | 19 |
| Blueprint Medicines Corp | 14 |
| Akebia Therapeutics Inc | 6 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 36 |
| C07D401/14 | 17 |
| A61P9/10 | 15 |
| A61P29/00 | 14 |
| C07D487/04 | 13 |